Alkermes
selectively expanded circulating and cells and demonstrated initial anti tumor activity | Alkermes
Company
Deck Type
Sector
Industry
Deck date
June 2021
Slide
26 of 31
Related slides by other companies
BioNTech
Investor Day
June 2022
long term in expansion and anti tumor activity of car cells in combination with vaccine and am | BioNTech
BioNTech
Results
November 2020
phase a anti tumor activity in immune recurrent refractory expansion | BioNTech
Immatics
Investor Presentation
November 2023
assessment of anti tumor activity in | Immatics
Apexigen
SPAC
March 2022
anti tumor effects of in melanoma single agent and anti combination efficacy is yor | Apexigen
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights